211 related articles for article (PubMed ID: 28099155)
1. Metformin promotes apoptosis in hepatocellular carcinoma through the CEBPD-induced autophagy pathway.
Tsai HH; Lai HY; Chen YC; Li CF; Huang HS; Liu HS; Tsai YS; Wang JM
Oncotarget; 2017 Feb; 8(8):13832-13845. PubMed ID: 28099155
[TBL] [Abstract][Full Text] [Related]
2. HMDB and 5-AzadC Combination Reverses Tumor Suppressor CCAAT/Enhancer-Binding Protein Delta to Strengthen the Death of Liver Cancer Cells.
Li CF; Tsai HH; Ko CY; Pan YC; Yen CJ; Lai HY; Yuh CH; Wu WC; Wang JM
Mol Cancer Ther; 2015 Nov; 14(11):2623-33. PubMed ID: 26358750
[TBL] [Abstract][Full Text] [Related]
3. Metformin Resensitizes Sorafenib-Resistant HCC Cells Through AMPK-Dependent Autophagy Activation.
Lai HY; Tsai HH; Yen CJ; Hung LY; Yang CC; Ho CH; Liang HY; Chen FW; Li CF; Wang JM
Front Cell Dev Biol; 2020; 8():596655. PubMed ID: 33681180
[TBL] [Abstract][Full Text] [Related]
4. CEBPD reverses RB/E2F1-mediated gene repression and participates in HMDB-induced apoptosis of cancer cells.
Pan YC; Li CF; Ko CY; Pan MH; Chen PJ; Tseng JT; Wu WC; Chang WC; Huang AM; Sterneck E; Wang JM
Clin Cancer Res; 2010 Dec; 16(23):5770-80. PubMed ID: 20971808
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H
Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093
[TBL] [Abstract][Full Text] [Related]
6. Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models.
You A; Cao M; Guo Z; Zuo B; Gao J; Zhou H; Li H; Cui Y; Fang F; Zhang W; Song T; Li Q; Zhu X; Yin H; Sun H; Zhang T
J Hematol Oncol; 2016 Mar; 9():20. PubMed ID: 26957312
[TBL] [Abstract][Full Text] [Related]
7. Metformin and AICAR regulate NANOG expression via the JNK pathway in HepG2 cells independently of AMPK.
Shen C; Ka SO; Kim SJ; Kim JH; Park BH; Park JH
Tumour Biol; 2016 Aug; 37(8):11199-208. PubMed ID: 26939902
[TBL] [Abstract][Full Text] [Related]
8. Action and clinical significance of CCAAT/enhancer-binding protein delta in hepatocellular carcinoma.
Liu P; Cao W; Ma B; Li M; Chen K; Sideras K; Duitman JW; Sprengers D; Khe Tran TC; Ijzermans JNM; Biermann K; Verheij J; Spek CA; Kwekkeboom J; Pan Q; Peppelenbosch MP
Carcinogenesis; 2019 Mar; 40(1):155-163. PubMed ID: 30325409
[TBL] [Abstract][Full Text] [Related]
9. Empagliflozin adjunct with metformin for the inhibition of hepatocellular carcinoma progression: Emerging approach for new application.
Abdelhamid AM; Saber S; Youssef ME; Gaafar AGA; Eissa H; Abd-Eldayem MA; Alqarni M; Batiha GE; Obaidullah AJ; Shahien MA; El-Ahwany E; Amin NA; Etman MA; Kaddah MMY; Abd El-Fattah EE
Biomed Pharmacother; 2022 Jan; 145():112455. PubMed ID: 34844106
[TBL] [Abstract][Full Text] [Related]
10. Regulation of SIRT1/AMPK axis is critically involved in gallotannin-induced senescence and impaired autophagy leading to cell death in hepatocellular carcinoma cells.
Kwon HY; Kim JH; Kim B; Srivastava SK; Kim SH
Arch Toxicol; 2018 Jan; 92(1):241-257. PubMed ID: 28676953
[TBL] [Abstract][Full Text] [Related]
11. ROCK2 promotes HCC proliferation by CEBPD inhibition through phospho-GSK3β/β-catenin signaling.
Li M; Zhou W; Yuan R; Chen L; Liu T; Huang D; Hao L; Xie Y; Shao J
FEBS Lett; 2015 Apr; 589(9):1018-25. PubMed ID: 25771860
[TBL] [Abstract][Full Text] [Related]
12. Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma.
Zhou X; Chen J; Yi G; Deng M; Liu H; Liang M; Shi B; Fu X; Chen Y; Chen L; He Z; Wang J; Liu J
Oncotarget; 2016 Jan; 7(1):873-84. PubMed ID: 26621849
[TBL] [Abstract][Full Text] [Related]
13. Negative regulation of Sirtuin 1 by AMP-activated protein kinase promotes metformin-induced senescence in hepatocellular carcinoma xenografts.
Zhou X; Chen J; Chen L; Feng X; Liu Z; Hu L; Zeng Z; Jia X; Liang M; Shi B; Yi G; Liu J
Cancer Lett; 2017 Dec; 411():1-11. PubMed ID: 28964787
[TBL] [Abstract][Full Text] [Related]
14. Low concentration of metformin induces a p53-dependent senescence in hepatoma cells via activation of the AMPK pathway.
Yi G; He Z; Zhou X; Xian L; Yuan T; Jia X; Hong J; He L; Liu J
Int J Oncol; 2013 Nov; 43(5):1503-10. PubMed ID: 23982736
[TBL] [Abstract][Full Text] [Related]
15. PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27
Tuo L; Xiang J; Pan X; Hu J; Tang H; Liang L; Xia J; Hu Y; Zhang W; Huang A; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Feb; 38(1):50. PubMed ID: 30717766
[TBL] [Abstract][Full Text] [Related]
16. Low-dose metformin suppresses hepatocellular carcinoma metastasis via the AMPK/JNK/IL-8 pathway.
Zhao C; Zheng L; Ma Y; Zhang Y; Yue C; Gu F; Niu G; Chen Y
Int J Immunopathol Pharmacol; 2024; 38():3946320241249445. PubMed ID: 38679570
[TBL] [Abstract][Full Text] [Related]
17. PSPH induces cell autophagy and promotes cell proliferation and invasion in the hepatocellular carcinoma cell line Huh7 via the AMPK/mTOR/ULK1 signaling pathway.
Zhang J; Wang E; Zhang L; Zhou B
Cell Biol Int; 2021 Feb; 45(2):305-319. PubMed ID: 33079432
[TBL] [Abstract][Full Text] [Related]
18. Nilotinib induces autophagy in hepatocellular carcinoma through AMPK activation.
Yu HC; Lin CS; Tai WT; Liu CY; Shiau CW; Chen KF
J Biol Chem; 2013 Jun; 288(25):18249-59. PubMed ID: 23677989
[TBL] [Abstract][Full Text] [Related]
19. Metformin reduces cisplatin-mediated apoptotic death of cancer cells through AMPK-independent activation of Akt.
Janjetovic K; Vucicevic L; Misirkic M; Vilimanovich U; Tovilovic G; Zogovic N; Nikolic Z; Jovanovic S; Bumbasirevic V; Trajkovic V; Harhaji-Trajkovic L
Eur J Pharmacol; 2011 Jan; 651(1-3):41-50. PubMed ID: 21114978
[TBL] [Abstract][Full Text] [Related]
20. Proscillaridin A inhibits hepatocellular carcinoma progression through inducing mitochondrial damage and autophagy.
Luo M; Liu Y; Liu N; Shao W; Ming L; Liu J; Xie Y
Acta Biochim Biophys Sin (Shanghai); 2021 Jan; 53(1):19-28. PubMed ID: 33201987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
